Pre-Op Blood Tests May Predict Post-Op Morbidity in Ovarian CA

Share this content:
Pre-Op Blood Tests May Predict Post-Op Morbidity in Ovarian CA
Pre-Op Blood Tests May Predict Post-Op Morbidity in Ovarian CA

MONDAY, Nov. 16, 2015 (HealthDay News) -- For patients with ovarian cancer, preoperative thrombocytosis and leukocytosis are associated with increased postoperative morbidity, according to a study published online Nov. 5 in Obstetrics & Gynecology.

Emma L. Barber, M.D., from the University of North Carolina at Chapel Hill, and colleagues examined the correlation between preoperative thrombocytosis or leukocytosis and postoperative morbidity or mortality in 1,072 patients with ovarian cancer undergoing primary surgery.

The researchers found that 9.6, 18.7, and 4.9 percent of patients had thrombocytosis, leukocytosis, and both, respectively. Both leukocytosis and thrombocytosis were associated with major complications (16.5 versus 10.3 percent [P = 0.01] and 19.4 versus 10.7 percent [P < 0.01], respectively), but not with postoperative death (3.0 versus 1.3 percent [P = 0.08] and 2.9 versus 1.5 percent [P = 0.30], respectively). Increased rates of both major complications and mortality were seen for patients with both thrombocytosis and leukocytosis (22.6 versus 10.9 [P < 0.001] and 5.7 versus 1.4 percent [P = 0.02], respectively). The correlations for leukocytosis and thrombocytosis with major complications persisted after adjustment for age, comorbidities, and surgical complexity (adjusted odds ratios, 1.78 and 2.16, respectively). Thrombocytosis and leukocytosis together correlated with increased risk of postoperative death (adjusted odds ratio, 5.4).

"Preoperative thrombocytosis or leukocytosis is associated with an increased risk of major postoperative complication," the authors write. "Patients with both thrombocytosis and leukocytosis experienced twice the rate of major complication and a four-fold increase in postoperative death."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »